This text is a result of machine translation.
Cancer cell therapy company raised CNY 500 million in D round
Baiji Shenzhou PD-1 inhibitor price dropped by 80%
Bid for Molecular Tech in China's Early-Stage Cancer Detection Market
China, with a population of 1.4 billion, has one of the largest gene pools in the world. How does its DNA tech-based cancer detection industry look? Listed on Nasdaq in 2020, Genetron Holdings Limited (Genetron Health) is taking a leading role.
Sep 09, 2020 03:08 PM
Bh009 new drug project independently researched and developed by Beihai biological Co., Ltd. was approved by China's clinical trials
Qiuzhen medical and tianguangshi have reached strategic cooperation to develop diagnostic kits and tumor drugs
Research
Technology, Healthcare, Consumer StaplesWIA2020 | Rising Tech Stars 2020: Global & China's 100
Research
Healthcare, Real Estate, IndustrialsTech for Global, Globalization Footprints of the Established and the New
Research
Industrials, Financials, Consumer StaplesLow-Carbon Industry Expansion - Key Studies From Chinese Companies
Sinopharm new coronavirus vaccine approved
Another protein component special medical food was approved, and the total number of approved products increased to 57
Phase I project of Guangzhou Pharmaceutical production base of nuocheng Jianhua was completed
BGI and Hanwei intelligent medical jointly launched mobile "two cancer" intelligent screening
Revenue and Net Profit of Wuxi Apptec Both Increased in 2020
Wuxi apptec said that the main reasons for the company's performance growth were the high growth of laboratories in China and the year-on-year growth of CDMO plate. China laboratory service is the core business of Wuxi apptec, accounting for more than 50% of its revenue. Its main business is small molecule drug discovery, drug analysis and testing.
Apr 01, 2021 04:39 PM
Asc41, a candidate drug for NASH, was administered to overweight and obese subjects in phase IB clinical trial
Fosun medicine: the new crown vaccine has been included in the domestic phase II clinical, and no serious adverse report has been received
Cell and gene therapy cro / cdmo xuanming cells completed a round of financing, led by Huagai capital and juming venture capital
Improving service quality and enabling industrial innovation!
Pfizer submitted to FDA for authorization of emergency use of new crown vaccine
The new crown vaccine developed by academician Chen Wei and kangxinuo biology can be stable for a long time from 2 to 8 degrees
Geli pharmaceutical: asc40 (tvb-2640) China has completed phase II NASH patients
Huawei 'Strikes Back': Global 5G Patent Battle Might Be Getting Started
Apr 18, 2021 10:53 PM
Digital Currency Electronic Payment: Not A Warning Sign for Alipay and WeChat Pay
Apr 16, 2021 10:07 AM
Three Opportunities Brought by Archegos Capital's Outburst
Apr 12, 2021 12:31 PM